A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

IsraelRecruitingPHASE2, PHASE3

Conditions

Generalized Myasthenia Gravis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Carolinas HealthCare System Neurosciences Institute - Neurology, Charlotte, North Carolina, United States
Contact: Study coordinator (Urvi Desai, MD) · clinicaltrials@argenx.com · 857-350-4834
Neurology Rare Disease Center, Denton, Texas, United States
Contact: Study coordinator (Diana Castro, MD) · clinicaltrials@argenx.com · 857-350-4834
University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Anna Jesus, MD) · clinicaltrials@argenx.com · 857-350-4834
Sydney Children's Hospital, Randwich, Australia
Contact: Study coordinator (Michelle Farrar, MD) · clinicaltrials@argenx.com · 857-350-4834
UZ Gent, Ghent, Belgium
Contact: Study coordinator (Nicolas Deconinck, MD) · nicolas.deconinck@huderf.be · +32473966619
Childrens Hospital of Eastern Ontario, Ottawa, Canada
Contact: Study coordinator (Hugh McMillan, MD) · clinicaltrials@argenx.com · 857-350-4834
Fakultni nemocnice Brno, Brno, Czechia
Contact: Study coordinator (Ondrej Havlin, MD) · havlin.ondrej@fnbrno.cz · +42532234581
Fakultni nemocnice Ostrava, Ostrava, Czechia
Contact: Study coordinator (Hana Medricka, MD) · hana.medricka@fno.cz · +420597373612
AP-HM- Hôpital de La Timone, Marseille, France
Contact: Study coordinator (Cecile Halbert, MD) · cecile.halbert@ap-hm.fr · +33491385605
Universitätsklinikum Essen, Essen, Germany
Contact: Study coordinator (Adela Della Marina, MD) · adela.dellamarina@uk-essen.de · +492017233618
Hadassah Medical Center- Ein Kerem, Jerusalem, Israel
Contact: Study coordinator (Talya Dor-Wollman, MD) · clinicaltrials@argenx.com · 857-350-4834
Schneider Children's Medical Center of Israel, Petah Tikvah, Israel
Contact: Study coordinator (Yoram Nevo, MD) · clinicaltrials@argenx.com · 857-350-4834
Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv, Israel
Contact: Study coordinator (Liora Sagi, MD) · clinicaltrials@argenx.com · 857-350-4834
Istituto G Gaslini Ospedale Pediatrico IRCCS, Genova, Italy
Contact: Study coordinator (Chiara Fiorillo, MD) · chiarafiorillo@edu.unige.it · +3901056363566
Leiden University Medical Center, Leiden, Netherlands
Contact: Study coordinator (Erik Harmen Niks, MD) · e.h.niks@lumc.nl · +310715262197
Uniwersyteckie Centrum Kliniczne w Gdansku, Gdansk, Poland
Contact: Study coordinator (Maria Mazurkiewicz-Beldzinska, MD) · mmazur@gumed.edu.pl · +48583492390
Neurologia Śląska Centrum Medyczne, Katowice, Poland
Contact: Study coordinator (Marek Smilowski, MD) · marek.smilowski2@gmail.com · +48500282494
Centralny Szpital Kliniczny - Uniwersyteckie Centrum Kliniczne WUM, Warsaw, Poland
Contact: Study coordinator (Anna Kostera-Pruszczyk, MD) · anna.kostera-pruszczyk@wum.edu.pl · +48225992858
Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain
Contact: Study coordinator (Teresa Sevilla Mantecón, MD) · sevilla_ter@gva.es · +34961244000
Hôpital Nestlé, Lausanne, Switzerland
Contact: Study coordinator (David Jacquier, MD) · clinicaltrials@argenx.com · 857-350-4834
Oxford Children's Hospital, Oxford, United Kingdom
Contact: Study coordinator (Sithara Ramdas, MD) · clinicaltrials@argenx.com · 857-350-4834

View source on ClinicalTrials.gov Contact study team (email)